Centre Leon Berard — Lyon

Public research footprint of Centre Leon Berard, compiled from the ClinicalTrials.gov public registry.

647

Registered studies

246

Active

104

Recruiting now

309

Completed

Stopped or withdrawn

Most-studied conditions

KRAS Altered Advanced or Metastatic Solid Tumors · Head and Neck Squamous Cell Carcinoma · Carcinoma, Non-Small-Cell Lung · Non-small Cell Lung Cancer

Recently updated registry entries

NCT05663866 — Premedication to Reduce Amivantamab Associated Infusion Related Reactions (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT01805271 — Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre Leon Berard?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.